17 Jul 2025, Thu

Breaking

Canada first-quarter GDP expands by 2.2% annualized rate, beating estimates

Ukraine yet to give decision on taking part in Istanbul talks

Trump says China has ‘totally violated’ Geneva deal with US on tariffs

Analysis-Global economy’s ‘sugar rush’ defies trade drama – for now

Czech growth helped by investment, exports, tariffs cloud outlook, central bank says

N2:PHAR1

N2:ARTI N2:CH N2:CMPNY N2:DE N2:DRUDEV N2:EREP N2:EUROP N2:HEA N2:HECA N2:INSGHT N2:ITEC N2:MEDREG N2:MTPIX N2:NAMER N2:NEWS1 N2:PHAG08 N2:PHAR N2:PHAR1 N2:PHMR N2:PUBL N2:SCI N2:TECH N2:US

Big Pharma bets on AI to speed up clinical trials

By Natalie Grover and Martin Coulter LONDON (Reuters) – Major drugmakers are using artificial intelligence...

N2:BLR N2:CMPNY N2:HEA N2:HECA N2:NAMER N2:PHAG08 N2:PHAR N2:PHAR1 N2:PHMR N2:PUBL N2:RESF N2:US

J&J expects double-digit 2023 profit growth after Kenvue spinoff

(Reuters) -Johnson & Johnson on Wednesday forecast double-digit profit growth for 2023 after spinning off...

N2:ACB N2:CMPNY N2:DEAL1 N2:EUROP N2:HEA N2:IE N2:INSR N2:JUDIC N2:MONOP N2:MRG N2:NAMER N2:NEWS1 N2:PHAG08 N2:PHAR1 N2:PHMR N2:PUBL N2:REGS N2:US N2:WASH

US FTC suspends challenge to block Amgen’s $27.8 billion deal for Horizon Therapeutics

(Reuters) -The U.S. Federal Trade Commission (FTC) has suspended its challenge of Amgen’s $27.8 billion...

N2:CMPNY N2:HEA N2:HECA N2:PHAG08 N2:PHAR1 N2:PUBL N2:TOPNWS N2:US

US FDA puts Gilead Sciences blood cancer drug studies on hold

(Reuters) -Gilead Sciences said on Monday the U.S. health regulator placed a clinical hold on...

N2:CMPNY N2:COVID N2:HECA N2:MTPIX N2:NAMER N2:PHAG08 N2:PHAR1 N2:PUBL N2:RES N2:RESF N2:US

Gilead quarterly profit falls on COVID sales drop, legal settlement charge

By Michael Erman (Reuters) -Gilead Sciences on Thursday reported lower second-quarter profit as costs from...

N2:BLR N2:CMPNY N2:CPROD N2:DRUDEV N2:HEA N2:HEADMI N2:HECA N2:MRCH N2:MTPIX N2:NAMER N2:PHAG08 N2:PHAR N2:PHAR1 N2:PHMR N2:PUBL N2:PXP N2:RES N2:RESF N2:RHEUMA N2:SCI N2:TOPNWS N2:US

AbbVie trims forecast for Humira sales drop on favorable coverage

By Leroy Leo and Patrick Wingrove (Reuters) -AbbVie on Thursday trimmed its 2023 view for...

N2:BLR N2:CMPNY N2:DVST N2:IPO N2:MTPIX N2:NAMER N2:PHAG08 N2:PHAR1 N2:PSNPR N2:PSNPR1 N2:PUBL N2:PXP N2:TOPNWS N2:US

J&J starts share exchange offer for consumer health spin-off Kenvue

(Reuters) -Johnson & Johnson said on Monday it had launched an exchange offer under which...

N2:BLR N2:CMPNY N2:COVID N2:DRUGEN N2:HEA N2:HECA N2:MEDDTE N2:MEDQ N2:MEDQ1 N2:MRCH N2:MTPIX N2:NAMER N2:NEWS1 N2:PHAG08 N2:PHAR1 N2:PHMR N2:PUBL N2:PXP N2:RES N2:RESF N2:US N2:VACCIN

J&J upbeat on 2023 as devices rebound post-COVID, shares jump

By Bhanvi Satija and Patrick Wingrove (Reuters) -Johnson & Johnson on Thursday expressed optimism for...

N2:CMPNY N2:DEAL1 N2:EUROP N2:FIN N2:MRCH N2:MRCH1 N2:MRG N2:NAMER N2:PHAG08 N2:PHAR1 N2:PUBL N2:US

US FTC seeks additional info on Pfizer’s proposed takeover of Seagen

(Reuters) -The US Federal Trade Commission (FTC) has sought additional information and documentary material related...

N2:BKRT N2:CASE1 N2:CLASS N2:CMPNY N2:CNCER N2:CONG08 N2:DBTR N2:HEA N2:HECA N2:JUDIC N2:MTPIX N2:NAMER N2:PHAG08 N2:PHAR1 N2:PUBL N2:US N2:USACA

Jurors urged to impose heavy punitive damages in J&J talc trial

By Brendan Pierson (Reuters) – Lawyers for a California man who says he developed a...

Uncategorized

Canada first-quarter GDP expands by 2.2% annualized rate, beating estimates

Uncategorized

Ukraine yet to give decision on taking part in Istanbul talks

Uncategorized

Trump says China has ‘totally violated’ Geneva deal with US on tariffs

Uncategorized

Analysis-Global economy’s ‘sugar rush’ defies trade drama – for now